<p><img src="https://static3.businessinsider.com/image/6034f7a7d920880018591711-1778/France vaccine.jpg" border="0" alt="France vaccine AstraZeneca box" data-mce-source="ALAIN JOCARD/AFP via Getty Images" data-mce-caption="A box containing vials of the AstraZeneca Covid-19 vaccine is pictured at the Foch hospital in Suresnes, on February 6, 2021, on the start of a vaccination campaign for health workers with the AstraZeneca/Oxford vaccine. - The top French medical authority Haute autorit de Sant has approved the vaccine for use in France, but only for people under 65, echoing decisions made in Sweden, Germany, Belgium and Switzerland over concerns about a lack of data on the effectiveness of the vaccine for over 65s."></p><p></p><bi-shortcode id="summary-shortcode" data-type="summary-shortcode" class="mceNonEditable" contenteditable="false">Summary List Placement</bi-shortcode><p>People receiving vaccines in the UK, France, and Germany are complicating the rollouts by trying to insist on receiving a particular shot, according to numerous reports.</p><p>In continental Europe, officials have pointed to unfilled appointments and empty vaccination hubs when the AstraZeneca dose is on offer.</p><p>The resistance appears to stem from trial data which suggested that the vaccine is less effective than shots made by Pfizer, the other vaccine being widely used in Europe.</p><p>In the UK, reports are more mixed, with anecdotal reports of some people insisting on the Pfizer jab, while others push for the the AstraZeneca one, citing its local credentials.</p><p>Here is what's happening:</p><ul><li>In Germany, hundreds of thousands of doses of the AstraZeneca shot are going unused, <a href="https://uk.news.yahoo.com/officials-plead-with-germans-to-accept-oxford-astra-zeneca-jab-after-after-vials-left-unused-172048124.html">per Yahoo! News</a>. Around 200 people were showing up for 3,800 daily appointment at a Berlin center offering only the AstraZeneca shot, <a href="https://www.thetimes.co.uk/article/germans-are-turning-down-oxford-astrazeneca-covid-vaccine-hpvh6rh6r">the Times of London reported</a>.</li><li>Officials in Austria and Bulgaria also reported public resistance to the AstraZeneca vaccine, <a href="https://www.france24.com/en/live-news/20210218-vaccine-poor-germans-shunning-astrazeneca-jab">France24 reported on February 18</a>.</li><li>In Italy, teachers and police have expressed concerns about the AstraZeneca vaccine, <a href="https://www.wsj.com/articles/these-doctors-want-to-pick-their-covid-19-vaccine-fearing-reactions-lower-efficacy-11613649603">the Wall Street Journal reported</a>. </li><li>In France, officials <a href="https://www.google.com/search'q=astrazeneca+15%25+flu-like&source=lnms&tbm=nws&sa=X&ved=2ahUKEwjNnfmG4__uAhWZGs0KHetbBi8Q_AUoAXoECAQQAw&biw=1440&bih=789">staggered the vaccination of health workers</a> after reports that several workers called in sick over flu-like side effects. Last month President Emmanuel Macron <a href="https://www.politico.eu/article/coronavirus-vaccine-europe-astrazeneca-macron-quasi-ineffective-older-pe/">cast doubt on its effectiveness</a>.</li><li>In Sweden, two regions <a href="https://www.thelocal.se/20210213/two-swedish-regions-pause-astra-jabs-after-side-effects">temporarily suspended</a> the rollout of AstraZeneca vaccines after a quarter of 400 hospital staff having received one jab reported mild side effects. </li></ul><p>In the UK, the picture is more complicated. <a href="https://www.washingtonpost.com/world/europe/covid-vaccines-choice-pfizer-astrazeneca/2021/02/20/0beaceb0-5f2f-11eb-a177-7765f29a9524_story.html">According to The Washington Post</a>, some Britons are canceling and rebooking vaccination appointments to secure the Pfizer shot.</p><p><img src="https://static3.businessinsider.com/image/6034f86cbed5c50011a2bff1-1778/Johnson thumbs up.jpg" border="0" alt="Johnson thumbs up vaccine astraZeneca UK" data-mce-source="Jeremy Selwyn-WPA Pool/Getty Images" data-mce-caption="Prime Minister Boris Johnson gestures as he visits a coronavirus vaccination centre at the Health and Well-being Centre in Orpington, south-east London on February 14, 2021 in London, England. The visit coincides with the country surpassing 15 million people who have received at least one dose of a covid-19 vaccine."></p><p>The outlet said the strategy was based on rumors and insider information about which centres have what doses.</p><p>It also pointed to the opposite phenomenonpeople insisting on getting the AstraZeneca shot because AstraZeneca is jointly headquartered in the UK, and developed its vaccine alongside the University of Oxford.</p><p>A doctor told the BBC on Sunday that his whereas his medical colleagues have a slight preference for the Pfizer vaccine, his patients tend to have a preference for the <a href="https://www.bbc.com/news/health-56132291">Oxford/AstraZeneca "made-in-Britain" vaccine</a>. </p><h2>Differences in data on efficacy</h2><p>The dynamic appears largely shaped by data from the Phase 3 trials of both vaccines.</p><p>As <a href="https://www.businessinsider.com/how-covid-vaccines-compare-cost-astrazeneca-oxford-pfizer-biontech-moderna-2020-11">reported by Insider's Isabella Jibilian in December</a>, question were raised about AstraZeneca's trials, when the company announced that the vaccine was 62% effective after two full doses, but 90% effective after half a dose and a full dose of the vaccine.</p><p>British regulators now put the <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca">efficacy of the vaccine at 70%</a>, <a href="https://www.washingtonpost.com/world/europe/covid-vaccines-choice-pfizer-astrazeneca/2021/02/20/0beaceb0-5f2f-11eb-a177-7765f29a9524_story.html">The Washington Post reported</a>, and the European Medicines Agency at 60%. </p><p>Compared with the reported 95% efficacy of the Pfizer vaccine in its trials, it would be easy to believe that the AstraZeneca vaccine does not perform as well. </p><p>However, Andrew Pollard, the lead scientist on the AstraZeneca vaccine development, told the Post that figures are not directly comparable.</p><p>"Unless you run the [Pfizer and AstraZeneca] trials head-to-head, you don't really know whether a 95 percent figure on trial and 62 percent in another trial mean the same thing," Pollard told The Washington Post.</p><p>Results from such a head-to-head trial should be available soon, he said. </p><p>Both the Pfizer and AstraZeneca vaccines "give very high protection against severe disease" and appear to "have good safety profiles" said the UK's <a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020">Joint Committee on Vaccination and Immunisation</a>, where Pollard is a lead scientist.</p><p>Pollard told the Post that he would personally "have whichever vaccine offered". </p><p>Real-world data in countries where the vaccines have been rolled out, such as <a href="https://www.businessinsider.com/pfizer-fda-uk-government-british-immunization-immunize-coronavirus-covid-19-2021-2">Israel</a> and <a href="https://www.businessinsider.com/covid-19-vaccines-cut-84-percent-virus-hospitalizations-uk-data-2021-2">the UK</a>, are starting to provide more clarity on the vaccines effectiveness.</p><p><a href="https://www.businessinsider.com/some-france-germany-uk-avoid-astrazeneca-jab-pfizer-reports-2021-2#comments">Join the conversation about this story »</a></p> <p>NOW WATCH: <a href="https://www.businessinsider.com/navy-usns-comfort-hospital-ship-new-york-coronavirus-covid-19-2020-3">How the Navy's largest hospital ship can help with the coronavirus</a></p> Click here to read full news..